Related Experiment Video
Updated: Aug 9, 2025

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Published on: February 26, 2018
Striatal μ-opioid receptor activation triggers direct-pathway GABAergic plasticity and induces negative affect
Wei Wang1, Xueyi Xie2, Xiaowen Zhuang2
1Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University Health Science Center, Bryan, TX 77807, USA; Interdisciplinary Faculty of Toxicology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
Abstract:
Withdrawal from chronic opioid use often causes hypodopaminergic states and negative affect, which may drive relapse. Direct-pathway medium spiny neurons (dMSNs) in the striatal patch compartment contain μ-opioid receptors (MORs). It remains unclear how chronic opioid exposure and withdrawal impact these MOR-expressing dMSNs and their outputs. Here, we report that MOR activation acutely suppressed GABAergic striatopallidal transmission in habenula-projecting globus pallidus neurons. Notably, withdrawal from repeated morphine or fentanyl administration potentiated this GABAergic transmission. Furthermore, intravenous fentanyl self-administration enhanced GABAergic striatonigral transmission and reduced midbrain dopaminergic activity. Fentanyl-activated striatal neurons mediated contextual memory retrieval required for conditioned place preference tests. Importantly, chemogenetic inhibition of striatal MOR+ neurons rescued fentanyl withdrawal-induced physical symptoms and anxiety-like behaviors. These data suggest that chronic opioid use triggers GABAergic striatopallidal and striatonigral plasticity to induce a hypodopaminergic state, which may promote negative emotions and relapse.
Insights
Chronic opioid use alters brain pathways, leading to withdrawal symptoms like anxiety and physical discomfort. Targeting specific brain cells (MOR+ neurons) can alleviate these opioid withdrawal effects and reduce relapse risk.
Area of Science:
- Neuroscience
- Neuropharmacology
- Addiction Research
Background:
- Chronic opioid use is linked to hypodopaminergic states and negative affect, contributing to relapse.
- Medium spiny neurons (dMSNs) expressing μ-opioid receptors (MORs) in the striatum are implicated in opioid effects, but their role during withdrawal is unclear.
Purpose of the Study:
- To investigate the impact of chronic opioid exposure and withdrawal on MOR-expressing dMSNs and their neural outputs.
- To elucidate the role of striatal MOR+ neurons in opioid withdrawal symptoms and relapse behaviors.
Main Methods:
- Electrophysiological recordings of GABAergic transmission in striatopallidal and striatonigral pathways.
- Intravenous fentanyl self-administration and subsequent behavioral assessments.
- Chemogenetic manipulation of striatal MOR+ neurons in rodent models.
Main Results:
- Acute MOR activation suppressed GABAergic striatopallidal transmission; withdrawal potentiated this transmission.
- Fentanyl self-administration enhanced striatonigral transmission and reduced midbrain dopamine activity.
- Inhibition of striatal MOR+ neurons ameliorated fentanyl withdrawal-induced physical symptoms and anxiety-like behaviors.
Conclusions:
- Chronic opioid use induces plasticity in GABAergic striatopallidal and striatonigral pathways.
- This plasticity contributes to a hypodopaminergic state, negative emotions, and potential relapse.
- Targeting striatal MOR+ neurons offers a potential therapeutic strategy for opioid withdrawal and addiction.
More Related Videos
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCR Desensitization

